Clarivate Q3 Earnings Conference Call - CLARIVATE PLC

Financial Performance:

• Q3 2026 revenue from continuing operations was $482 million; year-to-date (YTD) reached nearly $1.5 billion, with a 5% YTD decline driven entirely by the strategic wind-down of the A&G books business.
• Q3 adjusted diluted EPS was $0.21 (up 3 cents YoY), bringing YTD EPS to $0.59 (a 20% increase YoY).
• Adjusted EBITDA for Q3 was flat YoY; YTD adjusted EBITDA was flat, reflecting low-margin disposals offset by strong cost discipline.
• Operating cash flow for Q3 was $166 million; free cash flow (FCF) was $110 million, down $5 million YoY due to higher taxes and working capital timing, partially offset by lower interest and capex.
• Year-to-date debt reduction totaled $293 million, including a $75 million Q3 repurchase of 2028 notes at a ~2% discount.

Guidance and Future Outlook:

• Full-year 2026 revenue guidance is $1.965 billion to $1.985 billion (down from prior year due to disposals); YTD organic revenue mix expected to reach 92–94%.
• Full-year 2026 adjusted EBITDA guidance is $865 million to $885 million, implying all profit growth occurs in Q4, with a midpoint margin of ~44%.
• Full-year 2026 adjusted EPS guidance is ~$0.75 (up ~9% at midpoint).
• Full-year 2026 FCF guidance is $320 million to $340 million, excluding seasonal LSNH flows and including $30 million in final transaction costs.
• 2027 outlook targets higher organic ACV and recurring revenue growth, increasing FCF, and further leverage reduction; full 2027 guidance expected in February.
• Q4 2026 recurring organic revenue growth is expected to exceed 2%, the highest quarterly rate in over three years.

Business Segments and Product Lines:

• Academia and Government (AMG): ~$1.2B franchise with 95% recurring organic revenue mix; organic ACV and subscription growth ~2%. Key win: France's Clément (Climate) modernized its national academic library system with a unified cloud platform. Web of Science Research Intelligence secured >100 institutional wins across 25 countries with a $20M sales pipeline for 2026-2027.
• Intellectual Property (IP): $800M franchise with 90% recurring organic revenue; recurring organic revenue grew nearly 1%, and ACV returned to positive growth for the first time in >3 years.
• IP1 Launch: New AI-native intelligence layer in development; currently working with >40 partners (including 15+ Fortune Global 500), with a sales pipeline of 151 customers. Initial release targets five purpose-built AI agents.
• AI Deployment: >80 in-market AI agents; platform handled >465 million AI API calls (2.5x YoY volume).
• Strategic Disposition: Completed sale of Life Science & Healthcare (LSNH) segment ahead of schedule; results presented as discontinued operations.

Market and Competitive Landscape:

• AMG covers 99% of the world's top 400 universities and powers 75% of national/regional research assessments.
• IP segment serves 90% of the top 100 R&D investors, 15,000+ IP customers, and 40 patent/trademark offices (including the five largest globally).
• USPTO selected Clarivate to power image search across the US trademark register, validating image recognition capabilities in core workflows.
• Competitive advantage cited as proprietary data, embedded workflows, and the "AI-led innovation web" distinguishing Clarivate from general-purpose AI.

Risks and Challenges:

• Currency Fluctuations: Weakening USD created a profit headwind in Q3 despite neutral revenue impact.
• Transaction Costs: One-time transaction costs of ~$70 million (including $30 million YTD) are non-recurring but impacted Q3/Q4 FCF.
• Product Wind-downs: Discontinuation of low-margin transactional IP products (approx. 1% of revenue) over the next 1-2 years.
• Execution Risk: Dependence on converting current sales pipelines (e.g., Web of Science, IP1) into recurring revenue at scale.

Management Commentary and Tone:

• Tone was confident and optimistic, characterizing Q3 as a "major milestone" in the company's transformation.
• Management emphasized a clear path to accelerating organic growth, expanding FCF, and reducing leverage.
• CEO Mahdi Shemtov stated, "Clarivate today is a different company... strategy is working," citing improved KPIs and customer validation of AI capabilities.
• CFO Michael Easton highlighted disciplined capital allocation, specifically using divestiture proceeds to repurchase debt at discounts.

Analyst Questions and Answers:

• ACV Drivers (Barclays): Management attributed Q3 ACV growth (1.8%) primarily to strong pricing (targeting ~3%) and improving volumes; targeting ~2% exit rate for the year.
• IP Growth Disconnect (Goldman Sachs): Clarified that while total organic revenue was flat due to discontinued transactional products, the core IP business is stabilizing with 1% recurring growth and positive ACV, driven by management changes and the IP1 platform.
• Debt Repurchase Strategy (Bank of America): Confirmed plans to use LSNH proceeds to repurchase 2028 and 2029 notes at discounts (2-3%) in Q4, balancing timing and capital structure optimization.

Other Key Points:

• LSNH segment generated $370M revenue and $120M EBITDA in 2026; results now treated as discontinued operations.
• Q4 revenue comparisons to prior year are expected to be favorable due to the completion of the A&G books wind-down in Q2 2026 and seasonal patent/trademark renewals.
• Cost efficiencies generated $40M in organic profit growth, accounting for the majority of margin expansion.
• IP1 is positioned as the "intelligence and agenting foundation" for the IP lifecycle, leveraging 1 billion+ interconnected data points.